Voyager Therapeutics Inc.
VYGR | NASDAQ
$3.12
+$0.04 (+1.30%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.17M | 2.59M | 15.34M | 13.37M | 5.2M | 6.47M | 6.28M | 24.63M | 29.58M | 19.52M | 90.06M | 4.61M | 4.85M | 150.48M | -1.55M | 41.09M | 712K | 658K | 28.07M | 1.48M | 1.36M | 6.5M |
Cost of Revenue | n/a | 932K | 33.55M | 35.87M | 31.33M | 31.53M | 32.81M | 30.24M | 31.95M | 1.2M | 1.34M | 25.86M | 21.99M | 18.57M | 14.55M | 19.34M | 12.53M | 14.35M | 14.02M | 17.91M | 19.51M | 22.35M |
Gross Profit | 3.17M | 1.66M | -18.22M | -22.5M | -26.13M | -25.05M | -26.53M | -5.61M | -2.37M | 18.32M | 88.73M | -21.25M | -17.13M | 131.91M | -16.1M | 21.75M | -11.82M | -13.69M | 14.05M | -16.43M | -18.15M | -15.85M |
Operating Income | -26.39M | -30.27M | -29.93M | -30.59M | -36.63M | -34.69M | -38.3M | -13.78M | -15.03M | -16.18M | 54.06M | -29.51M | -25.43M | 122.88M | -24.56M | 14.44M | -19.37M | -21.35M | 5.7M | -25.15M | -28.59M | -25.59M |
Interest Income | 1.53M | 1.91M | 2.11M | 2.39M | 2.83M | 3.29M | 3.99M | 4.58M | 4.89M | 4.87M | 3.15M | 3.43M | 3.27M | 1.86M | 976K | 545K | 219K | 31K | n/a | 121K | 48K | 19K |
Pretax Income | -24.45M | -27.92M | -27.42M | -27.81M | -33.37M | -30.98M | -33.9M | -9M | -10.12M | -11.32M | 57.22M | -25.72M | -22.15M | 124.75M | -23.61M | 17.62M | -19.09M | -21.32M | 5.71M | -25.14M | -30.12M | -21.65M |
Net Income | -24.47M | -27.94M | -27.43M | -27.89M | -33.38M | -31.02M | -34.49M | -9.04M | -10.14M | -11.33M | 56.4M | -25.9M | -22.21M | 124.04M | -23.63M | 17.62M | -19.09M | -21.32M | 5.71M | -25.14M | -30.12M | -21.65M |
Selling & General & Admin | 7.52M | 8.26M | 8.22M | 8.09M | 10.5M | 9.64M | 8.99M | 8.17M | 10.15M | 8.61M | 10.24M | 8.26M | 8.29M | 9.03M | 8.46M | 7.31M | 7.55M | 7.66M | 8.35M | 8.71M | 10.44M | 9.74M |
Research & Development | 22.04M | 24.6M | 35.95M | 35.87M | 31.33M | 31.53M | 35.58M | 30.24M | 34.45M | 25.9M | 24.42M | 25.86M | 21.99M | 18.57M | 14.55M | 19.34M | 12.53M | 14.35M | 14.02M | 17.91M | 19.51M | 22.35M |
Other Expenses | n/a | -932K | -32.45M | -35.87M | -31.33M | -31.53M | -32.81M | -30.24M | -31.95M | n/a | n/a | -25.86M | -21.99M | -18.57M | -14.55M | -19.34M | -12.53M | -14.35M | -14.02M | -17.91M | -19.51M | -22.35M |
Operating Expenses | 29.56M | 31.93M | 11.72M | 8.09M | 10.5M | 9.64M | 11.77M | 8.17M | 12.65M | 34.5M | 34.66M | 8.26M | 8.29M | 9.03M | 8.46M | 7.31M | 7.55M | 7.66M | 8.35M | 8.71M | 10.44M | 9.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 643K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.56M | 32.86M | 45.27M | 43.96M | 41.83M | 41.17M | 44.58M | 38.41M | 44.6M | 35.7M | 36M | 34.12M | 30.28M | 27.6M | 23.01M | 26.64M | 20.08M | 22.01M | 22.37M | 26.63M | 29.94M | 32.09M |
Income Tax Expense | 20K | 14K | 9K | 83K | 15K | 37K | 584K | 43K | 24K | 14K | 822K | 177K | 59K | 704K | 16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.55M | 59.5M | 58.69M | 58.8M | 58.67M | 58.35M | 57.97M | 57.85M | 57.72M | 57.12M | 43.98M | 43.86M | 43.52M | 40.63M | 38.55M | 38.51M | 38.17M | 38.05M | 37.8M | 37.52M | 37.58M | 37.33M |
Shares Outstanding (Diluted) | 60.55M | 59.5M | 58.69M | 58.8M | 58.67M | 58.35M | 57.97M | 57.85M | 57.72M | 57.12M | 45.08M | 43.86M | 43.52M | 42.16M | 38.55M | 39.57M | 38.3M | 38.05M | 37.8M | 37.78M | 37.58M | 37.5M |
EPS (Basic) | -0.40 | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 | -0.59 | -0.16 | -0.18 | -0.20 | 1.28 | -0.59 | -0.51 | 3.05 | -0.61 | 0.46 | -0.49 | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
EPS (Diluted) | -0.40 | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 | -0.59 | -0.16 | -0.18 | -0.20 | 1.25 | -0.59 | -0.51 | 2.94 | -0.61 | 0.45 | -0.49 | -0.56 | 0.15 | -0.67 | -0.80 | -0.58 |
EBITDA | -22.61M | -26.99M | -26.37M | -26.88M | -32.3M | -29.97M | -32.89M | -7.87M | -11.13M | -10.12M | 58.55M | -24.78M | -21.06M | 125.82M | -22.78M | 18.97M | -17.88M | -18.51M | 7.83M | -23.91M | -28.94M | -24.32M |
EBIT | -24.45M | -27.92M | -27.42M | -27.81M | -33.37M | -30.98M | -33.9M | -9M | -12.53M | -11.32M | 57.22M | -25.72M | -22.15M | 124.75M | -23.61M | 17.62M | -19.09M | -21.32M | 6.35M | -25.14M | -30.12M | -25.59M |
Depreciation & Amortization | 1.84M | 932K | 1.05M | 932K | 1.07M | 1.01M | 1.01M | 1.13M | 1.39M | 1.2M | 1.34M | 945K | 1.09M | 1.08M | 834K | 1.34M | 1.2M | 2.81M | 1.48M | 1.22M | 1.19M | 1.27M |
Add to Watchlist
Select watchlists to add or remove VYGR